2021 USPSTF Recommendation Boosted Colorectal Cancer Screening

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Oct. 4, 2024 -- Uptake of colorectal cancer (CRC) screening increased after the 2021 U.S. Preventive Services Task Force (USPSTF) recommendation that all average-risk individuals aged 45 to 49 years should receive screening, according to a study published online Oct. 3 in JAMA Network Open.

Sunny Siddique, M.P.H., from the Yale School of Public Health in New Haven, Connecticut, and colleagues evaluated changes in CRC screening uptake among average-risk individuals aged 45 to 49 years following the 2021 USPSTF recommendation. The analysis included claims data from 10 million commercially insured Blue Cross Blue Shield beneficiaries (2017 through 2022).

The researchers found that mean screening uptake increased from 0.50 to 1.51 percent from before the recommendation to after the recommendation. While there was an absolute change of 1.01 percentage points, there was no significant relative change. Beneficiaries residing in areas with the highest socioeconomic status experienced the largest absolute change in screening (1.25 percentage points versus 0.75 percentage points for areas with the lowest socioeconomic status), but these relative changes were not significant. After the recommendation, the screening uptake rate increased fastest among average-risk beneficiaries residing in the areas with highest socioeconomic status (0.24 percentage points every two months) and metropolitan areas (0.20 percentage points every two months).

"Although CRC screening was expectedly higher among high-risk individuals, the twofold increase in screening among average-risk beneficiaries suggests a shift in the screening paradigm of this newly included age group," the authors write.

Two authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords